Halmos Emma P
Department of Gastroenterology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:69-72. doi: 10.1111/jgh.13701.
Irritable bowel syndrome (IBS) is heterogeneous. Patients need proper assessment and explanation of IBS pathophysiology and appropriate therapies. A low FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) diet effectively reduces symptoms in 75% of patients. Best treatment for those nonresponsive will depend on the pathophysiological basis for symptom genesis, with the following possible abnormalities: (i) Visceral hypersensitivity and/or enhanced gut-brain communication: a low FODMAP diet is mainly targeted for this patient group. A dietitian may also recommend antispasmodic agents, including peppermint oil. Another dietary treatment is a low food chemical diet, although this diet is often extremely limited, and therefore, not suited for some populations. Psychological therapies are also clinically beneficial. (ii) Altered motility: in patients with fast transit, a dietitian may recommend a reduction in all FODMAPs or targeted monosaccharides and disaccharides, which are more osmotic in nature. If not effective, patients may benefit from psyllium, which has an exceptional water-holding capacity aimed to promote more formed stools. Patients with slow or uncoordinated transit are often more difficult to treat. Dietary interventions have some success and usually comprise a combination of adequate fiber and fluid, osmotic laxatives, and stimulating agents such as caffeine, senna, and exercise. (iii) Altered microbiome: supplementary probiotics and prebiotics have weak evidence of efficacy with some notable exceptions. A dietitian may trial supplementary Bifidobacterium infantis or oligosaccharides, usually as an adjunct therapy. Guidance from a dietitian will encompass dietary methods to treat IBS but additionally identify where dietary treatment is not indicated to ensure that diet is correctly used and patients are not nutritionally or psychologically compromised.
肠易激综合征(IBS)具有异质性。患者需要对IBS的病理生理学进行适当评估和解释,并接受合适的治疗。低FODMAP(可发酵寡糖、双糖、单糖和多元醇)饮食可有效减轻75%患者的症状。对于那些无反应的患者,最佳治疗方法将取决于症状产生的病理生理基础,可能存在以下异常情况:(i)内脏高敏感性和/或肠-脑交流增强:低FODMAP饮食主要针对该患者群体。营养师也可能会推荐解痉剂,包括薄荷油。另一种饮食疗法是低食物化学物饮食,尽管这种饮食通常限制极大,因此不适合某些人群。心理疗法在临床上也有益处。(ii)动力改变:对于肠道传输快的患者,营养师可能会建议减少所有FODMAP或特定的单糖和双糖,这些物质本质上渗透性更强。如果无效,患者可能会从车前草中获益,其具有出色的保水能力,旨在促进形成更成形的粪便。肠道传输慢或不协调的患者通常更难治疗。饮食干预有一定成效,通常包括适量的纤维和液体、渗透性泻药以及刺激剂,如咖啡因、番泻叶和运动。(iii)微生物群改变:补充益生菌和益生元的疗效证据不足,但有一些显著例外。营养师可能会尝试补充婴儿双歧杆菌或寡糖,通常作为辅助疗法。营养师的指导将包括治疗IBS的饮食方法,但还会确定哪些情况不适合饮食治疗,以确保正确使用饮食,且患者在营养或心理方面不受影响。